Developing educational materials to aid in Alzheimer's blood biomarker disclosure
Individuals with mild cognitive impairment (MCI) find value in receiving blood biomarker results.Additional risk reduction information is helpful when communicating dementia risk.Individuals prefer medical information communicated visually.
Authors
- Corey J. Bolton (ORCID: https://orcid.org/0000-0002-1715-5370)
- Angela Lee Jefferson (ORCID: https://orcid.org/0000-0002-8245-0587)
- Sydney Wilhoite
- Raymond R. Romano (ORCID: https://orcid.org/0000-0001-6121-8263)
- Dominic Roby
- Marina Velez
Institutions
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Alzheimer s & Dementia Translational Research & Clinical Interventions
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1002/trc2.70182
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Alzheimer's Association
- Vanderbilt University
- Vanderbilt University Medical Center